Docetaxel injection concentrate, 20 mg/mL, 1 mL vial, Rx only, Winthrop U.S. a business of Sanofi-Aventis U.S. LLC., NDC 0955-1020-01
Published May 9, 2018 · Recall initiated: April 27, 2018
Summary
FDA records drug Class II recall D-0804-2018, published May 9, 2018 and initiated April 27, 2018. Recalling firm: Sanofi-Aventis U.S. LLC; Status: Terminated; Reported quantity: 19580 vials; Lot: Lot #: 7F307A, 7F307C, Exp 01/2019. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Superpotent drug: over-concentrated vials of Docetaxel injection concentrate 20 mg/mL may have been distributed.
What to do
Voluntary: Firm initiated · Letter
Get an email if DOCETAXEL has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- DOCETAXEL
- Manufacturer
- Sanofi-Aventis U.S. LLC
- Distributor
- US nationwide
- Lot
- Lot #: 7F307A, 7F307C, Exp 01/2019
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADocetaxel Injection, USP, 160 mg per 16 mL (10 mg per mL), 1 x 16 mL Multi-Dose Vial, Rx only, Mfd. for SagentJune 19, 2024
- FDADocetaxel Injection, USP, 80 mg per 8 mL (10 mg per mL), 1 x 8 mL Multi-Dose Vial, Rx only, Mfd. for SagentJune 19, 2024
- FDADocetaxel Injection USP, 80 mg/4 mL, (20 mg/mL), One-Vial Formulation, Rx only, Mfd By: Dr. Reddy'sMarch 20, 2019
- FDALevofloxacin in 5% Dextrose Injection, 750 mg Levofloxacin (5 mg/mL) in 150 mL of 5% Dextrose, For IntravenousMay 9, 2018
- FDACinnamon Sugar Cookie, Brand name Columbia Gorge Gluten Free. Packaged in a plastic bag for wholesaleMay 9, 2018
- FDALevetiracetam in 0.54% Sodium Chloride Injection, 1,500 mg per 100 mL (15 mg/mL), For Intravenous InfusionMay 9, 2018
Questions about this recall
Was Docetaxel injection concentrate, 20 mg/mL, 1 mL vial, Rx only, Winthrop U.S. a business of Sanofi-Aventis U.S. LLC., NDC 0955-1020-01 recalled?
Yes. FDA published recall D-0804-2018 on May 9, 2018. Reported hazard: Superpotent drug: over-concentrated vials of Docetaxel injection concentrate 20 mg/mL may have been distributed.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: DOCETAXEL.